Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.
종목 코드 TWST
회사 이름Twist Bioscience Corp
상장일Oct 31, 2018
설립일2013
CEODr. Emily M. Leproust, Ph.D.
직원 수923
유형Ordinary Share
회계 연도 종료Oct 31
주소681 Gateway Blvd.
도시SOUTH SAN FRANCISCO
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호94080
전화18007190671
웹사이트https://www.twistbioscience.com/
종목 코드 TWST
상장일Oct 31, 2018
설립일2013
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음